In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be ...

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive ...

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL) , TECNIS Odyssey, in the US. The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS ...

Dr. London discusses a case of diabetic macular edema (DME) with persistent subretinal fluid, emphasizing the diagnostic ...

Dr. London discusses the implications of faricimab and aflibercept 8 mg in treating retinal diseases, highlighting their mechanisms, efficacy data, and potential to enhance patient outcomes in ...

Dr. London examines a case of longstanding bilateral neovascular age-related macular degeneration (AMD), focusing on the patient's clinical history, treatment challenges, and the potential impact of ...

Lloyd Clark, MD, discusses the evolution and current practices in the treatment of common retinal diseases such as age-related macular degeneration, diabetic macular edema, and retinal vein occlusion.